Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stenzinger

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|July 23, 2014
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic roleA Warth, J Cortis, A Soltermann, et al.
Blood Cancer Journal|August 23, 2014
KIT mutations in primary mediastinal B-cell lymphomaP D Nagel, A Stenzinger, F M Feld, et al.
The British Journal of Dermatology|November 2, 2021
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathwayK Maurus, C Kosnopfel, H Kneitz, et al.
NPJ Precision Oncology|June 10, 2022
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)E Rempel, K Kluck, S Beck, et al.
ESMO Open|February 6, 2026
Mismatch repair deficiency and microsatellite instability in adrenocortical carcinomaB Altieri, S Kircher, S Herterich, et al.
ESMO Open|November 6, 2025
A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortiumS F Haj Mohammad, H van der Pol, E Vrdoljak, et al.
ESMO Open|June 5, 2021
Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancerR A El Shafie, K Seidensaal, F Bozorgmehr, et al.
International Journal of Cancer|September 27, 2018
Identification of a highly lethal V3<sup>+</sup> TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinomaP Christopoulos, M Kirchner, F Bozorgmehr, et al.
The British Journal of Dermatology|June 29, 2021
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinomaD Westphal, M Garzarolli, M Sergon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2015
Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalenceI Tinhofer, K Jöhrens, U Keilholz, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|July 23, 2014
Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic roleA Warth, J Cortis, A Soltermann, et al.
Blood Cancer Journal|August 23, 2014
KIT mutations in primary mediastinal B-cell lymphomaP D Nagel, A Stenzinger, F M Feld, et al.
The British Journal of Dermatology|November 2, 2021
Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathwayK Maurus, C Kosnopfel, H Kneitz, et al.
NPJ Precision Oncology|June 10, 2022
Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD)E Rempel, K Kluck, S Beck, et al.
ESMO Open|February 6, 2026
Mismatch repair deficiency and microsatellite instability in adrenocortical carcinomaB Altieri, S Kircher, S Herterich, et al.
ESMO Open|November 6, 2025
A comprehensive assessment of the existing landscape of personalized cancer medicine in the European Union, on behalf of the PCM4EU consortiumS F Haj Mohammad, H van der Pol, E Vrdoljak, et al.
ESMO Open|June 5, 2021
Effect of timing, technique and molecular features on brain control with local therapies in oncogene-driven lung cancerR A El Shafie, K Seidensaal, F Bozorgmehr, et al.
International Journal of Cancer|September 27, 2018
Identification of a highly lethal V3<sup>+</sup> TP53<sup>+</sup> subset in ALK<sup>+</sup> lung adenocarcinomaP Christopoulos, M Kirchner, F Bozorgmehr, et al.
The British Journal of Dermatology|June 29, 2021
High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinomaD Westphal, M Garzarolli, M Sergon, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2015
Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalenceI Tinhofer, K Jöhrens, U Keilholz, et al.
Pageof 7